IONIS PHARMACEUTICALS INC Insider Trading for July 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC for July 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 10.29 | 10,000 | 102,900 | 12,250 | |
Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 59.29 | 10,000 | 592,900 | 15,041 | 25 K to 15 K (-39.93 %) |
Jul 26 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 10.29 | 10,000 | 102,900 | 25,041 | 15 K to 25 K (+66.48 %) |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,000 | 7,250 | 4,904 | |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 106,642 | |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 1,000 | 55,350 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,000 | 7,250 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 55.35 | 10,000 | 553,500 | 38,014 | 48 K to 38 K (-20.83 %) |
Jul 24 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 48,014 | 38 K to 48 K (+26.31 %) |
Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Option Exercise | C | 0.00 | 28,884,540 | 0 | 0 | |
Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 8.00 | 3,125,000 | 25,000,000 | 45,447,879 | 42.3 M to 45.4 M (+7.38 %) |
Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | J | 0.00 | 13,438,339 | 0 | 42,322,879 | 28.9 M to 42.3 M (+46.52 %) |
Jul 21 2017 | ISIS | IONIS PHARMACEUTIC ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | C | 0.00 | 28,884,540 | 0 | 28,884,540 | 0 to 28.9 M |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 5,904 | |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 116,642 | |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 1,500 | 78,675 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.45 | 15,000 | 786,750 | 38,014 | 53 K to 38 K (-28.29 %) |
Jul 18 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Sell | S | 51.35 | 309 | 15,867 | 11,626 | 11.9 K to 11.6 K (-2.59 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | SVP, Antisense Drug ... | Buy | J | 40.66 | 163 | 6,627 | 11,935 | 11.8 K to 11.9 K (+1.38 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | COO | Buy | J | 40.66 | 90 | 3,659 | 25,741 | 25.7 K to 25.7 K (+0.35 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | J | 40.66 | 134 | 5,448 | 10,433 | 10.3 K to 10.4 K (+1.30 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 40.66 | 104 | 4,228 | 10,392 | 10.3 K to 10.4 K (+1.01 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 40.66 | 196 | 7,968 | 13,158 | 13 K to 13.2 K (+1.51 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Boyce Sarah | Chief Business Offi ... | Buy | J | 40.66 | 17 | 691 | 5,269 | 5.3 K to 5.3 K (+0.32 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | J | 40.66 | 253 | 10,286 | 15,041 | 14.8 K to 15 K (+1.71 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 7,404 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 1,538 | 22,593 | 131,642 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 13,462 | 97,600 | 0 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.10 | 1,500 | 78,150 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.30 | 1,538 | 80,437 | 38,014 | 39.6 K to 38 K (-3.89 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 1,538 | 22,593 | 39,552 | 38 K to 39.6 K (+4.05 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.08 | 13,462 | 701,101 | 38,014 | 51.5 K to 38 K (-26.15 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 13,462 | 97,600 | 51,476 | 38 K to 51.5 K (+35.41 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 2,469 | 0 | 36,249 | 33.8 K to 36.2 K (+7.31 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 2,469 | 0 | 7,127 | 4.7 K to 7.1 K (+53.01 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 1,600 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Option Exercise | M | 0.00 | 2,001 | 0 | 4,936 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 2,001 | 0 | 6,815 | 4.8 K to 6.8 K (+41.57 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 2,469 | 0 | 10,127 | 7.7 K to 10.1 K (+32.24 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 3,406 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 3,406 | 0 | 9,627 | 6.2 K to 9.6 K (+54.75 %) |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 52.22 | 16,000 | 835,520 | 16,000 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 0.00 | 2,667 | 0 | 2,667 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 2,469 | 0 | 3,999 | |
Jul 03 2017 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 2,469 | 0 | 91,427 | 89 K to 91.4 K (+2.78 %) |